You're Taking Omega-3 and Still Inflamed. Here's the Biological Reason.

FADS1 encodes an enzyme called delta-5 desaturase. This enzyme is the final step in converting short-chain omega-3 (ALA from plants, seeds, flax) into long-chain omega-3 (EPA and DHA) that your body actually uses to fight inflammation. Without this enzyme working properly, the omega-3 you eat simply sits in your cells inert.

The rs174537 variant in FADS1, carried by approximately 30-40% of the population, reduces delta-5 desaturase activity. People with this variant produce 20-30% less EPA and DHA from plant sources, meaning you can eat flax daily and still be functionally deficient in the active forms that reduce inflammation. Your bloodwork might show “normal” omega-3, but your cells don’t have enough of the forms that matter.

You likely noticed that increasing plant-based omega-3 didn’t help, but you weren’t sure why. Fish oil helped slightly more, but not as much as it helps other people. You may have assumed your body just “doesn’t respond well” to omega-3. Actually, your body needs to start with preformed long-chain omega-3 because the conversion step is compromised.

FADS2 encodes delta-6 desaturase, the first critical step in converting plant-based omega-3 (ALA) into its longer-chain forms. This enzyme is a gatekeeper; if it doesn’t work, nothing downstream works either, no matter how much omega-3 you consume.

The rs1535 variant in FADS2, present in roughly 30-40% of people, reduces delta-6 desaturase activity by 30-50%. With a FADS2 variant, your conversion of ALA to the next step (EPADP) is already compromised before delta-5 desaturase ever gets involved. Many people have variants in both FADS1 and FADS2, which creates a double bottleneck: even if you eat omega-3, two critical enzyme steps are underperforming.

This explains why you may have felt like a non-responder to plant-based omega-3 sources. You weren’t being stubborn or unlucky. Your genetic blueprint included a slowdown in the first step of the conversion pathway. The inflammation persisted because the active compounds never reached the concentration they needed to.

VDR is not a vitamin D storage gene; it’s a sensitivity gene. It encodes the receptor that allows your cells to actually “read” the vitamin D signal and activate anti-inflammatory gene expression. If VDR doesn’t work well, your cells ignore vitamin D entirely, even if blood levels are normal.

Variants like BsmI, FokI, and TaqI in VDR are carried by roughly 30-50% of people. These variants reduce your cellular ability to activate vitamin D signaling, meaning you can have optimal blood levels of vitamin D and still have functionally deficient cellular response. Your immune cells, especially regulatory T cells that suppress excess inflammation, simply aren’t responding to the vitamin D signal.

You may have had vitamin D supplementation recommended, tested your level, found it “normal,” and still experienced persistent inflammation. That’s a VDR variant. Your blood level is fine; your cells’ ability to listen to vitamin D is impaired. This is why some people feel dramatically better on vitamin D while others see no effect.

PPARG is a master switch for anti-inflammatory signaling. When it’s activated, your immune system calms down, your cells reduce inflammatory cytokine production, and your body returns to baseline. PPARG is the target of certain diabetes medications precisely because of this potent anti-inflammatory effect.

Variants in PPARG (such as Pro12Ala, rs1801282) alter how readily this anti-inflammatory switch can be flipped. People with certain PPARG variants have a harder time activating the anti-inflammatory cascade, even when they have adequate omega-3 and vitamin D. Your immune system tends to stay in a more activated state, and standard anti-inflammatory supplements have less effect because the genetic brake on inflammation is weaker.

You may have noticed that other people calm their inflammation with diet changes alone, while you need multiple interventions. You may have tried omega-3, cut inflammatory foods, and still fought constant low-grade inflammation. This is because PPARG variants make you more prone to immune activation. The supplements help, but your baseline inflammatory tone is genetically set higher.

APOE controls how your body handles cholesterol, triglycerides, and other lipids. It determines the shape of your lipoproteins and how effectively they’re cleared from your bloodstream. APOE also modulates neuroinflammation and systemic immune response. The three common variants (E2, E3, E4) create very different patterns of lipid handling and inflammatory potential.

The APOE4 allele, carried by roughly 25% of the population, is associated with higher circulating triglycerides, higher inflammatory markers, and reduced ability to clear certain types of lipids from the bloodstream. People with APOE4 variants often have higher baseline inflammation and may paradoxically react poorly to very high omega-3 intake if it comes from sources with high omega-6 or if their conversion is already impaired. Their immune systems are more reactive to dietary lipids overall.

You may have found that increasing omega-3 actually made you feel worse, or that blood inflammation markers got worse despite supplementation. This happens in APOE4 carriers when the lipid quality and ratio are off. The issue isn’t omega-3 itself; it’s that APOE4 creates a lipid-sensitive phenotype where the quality and balance of dietary fats matters intensely.

MTHFR isn’t just about folate conversion; it’s about methylation capacity. Your immune system depends on proper methylation to create molecules that suppress inflammation and activate regulatory T cells. If methylation is compromised, your immune system skews toward activation and inflammation, regardless of omega-3 status.

The C677T variant in MTHFR, carried by approximately 40% of people with European ancestry, reduces enzyme activity by 35-70%. People with MTHFR C677T have impaired methylation, which means their immune system can’t efficiently generate anti-inflammatory signals even when other pathways are working fine. You can have normal omega-3, normal vitamin D, and optimal PPARG function, but if methylation is broken, inflammation persists.

You’ve likely noticed that you need more recovery after stress, that you’re sensitive to certain foods that other people tolerate, and that your inflammation seems driven partly by stress and immune sensitivity rather than just dietary lipids. This is MTHFR. The methylation pathway is fatigued, so your regulatory immune cells can’t do their job. Omega-3 helps, but it can’t overcome a broken methylation cycle.